Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2883350403', 'doi': 'https://doi.org/10.7326/l18-0209', 'title': 'Use of Immune Checkpoint Inhibitors in the Treatment of Patients With Cancer and Preexisting Autoimmune Disease', 'display_name': 'Use of Immune Checkpoint Inhibitors in the Treatment of Patients With Cancer and Preexisting Autoimmune Disease', 'publication_year': 2018, 'publication_date': '2018-07-16', 'ids': {'openalex': 'https://openalex.org/W2883350403', 'doi': 'https://doi.org/10.7326/l18-0209', 'mag': '2883350403', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/30014109'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.7326/l18-0209', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S119722071', 'display_name': 'Annals of Internal Medicine', 'issn_l': '0003-4819', 'issn': ['0003-4819', '1539-3704'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316812', 'host_organization_name': 'American College of Physicians', 'host_organization_lineage': ['https://openalex.org/P4310316812'], 'host_organization_lineage_names': ['American College of Physicians'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'letter', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5000817838', 'display_name': 'Noha Abdel‐Wahab', 'orcid': 'https://orcid.org/0000-0002-7621-9266'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Noha Abdel-Wahab', 'raw_affiliation_strings': ['University of Texas MD Anderson Cancer Center, Houston, Texas (N.A., M.S., M.A.L., M.E.S.)'], 'affiliations': [{'raw_affiliation_string': 'University of Texas MD Anderson Cancer Center, Houston, Texas (N.A., M.S., M.A.L., M.E.S.)', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5008096735', 'display_name': 'Mohsin Shah', 'orcid': 'https://orcid.org/0000-0002-3450-4843'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Mohsin Shah', 'raw_affiliation_strings': ['University of Texas MD Anderson Cancer Center, Houston, Texas (N.A., M.S., M.A.L., M.E.S.)'], 'affiliations': [{'raw_affiliation_string': 'University of Texas MD Anderson Cancer Center, Houston, Texas (N.A., M.S., M.A.L., M.E.S.)', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5032923754', 'display_name': 'María A. López-Olivo', 'orcid': 'https://orcid.org/0000-0002-5165-8393'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Maria A. Lopez-Olivo', 'raw_affiliation_strings': ['University of Texas MD Anderson Cancer Center, Houston, Texas (N.A., M.S., M.A.L., M.E.S.)'], 'affiliations': [{'raw_affiliation_string': 'University of Texas MD Anderson Cancer Center, Houston, Texas (N.A., M.S., M.A.L., M.E.S.)', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5065216794', 'display_name': 'María E. Suarez‐Almazor', 'orcid': 'https://orcid.org/0000-0001-5381-5797'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Maria E. Suarez-Almazor', 'raw_affiliation_strings': ['University of Texas MD Anderson Cancer Center, Houston, Texas (N.A., M.S., M.A.L., M.E.S.)'], 'affiliations': [{'raw_affiliation_string': 'University of Texas MD Anderson Cancer Center, Houston, Texas (N.A., M.S., M.A.L., M.E.S.)', 'institution_ids': ['https://openalex.org/I1343551460']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': None, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 57, 'citation_normalized_percentile': {'value': 0.999018, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 96, 'max': 97}, 'biblio': {'volume': '169', 'issue': '2', 'first_page': '133', 'last_page': '133'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10158', 'display_name': 'Cancer Immunotherapy and Biomarkers', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10158', 'display_name': 'Cancer Immunotherapy and Biomarkers', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11157', 'display_name': 'Chronic Lymphocytic Leukemia Research', 'score': 0.9954, 'subfield': {'id': 'https://openalex.org/subfields/2716', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11485', 'display_name': 'Gastrointestinal Tumor Research and Treatment', 'score': 0.9924, 'subfield': {'id': 'https://openalex.org/subfields/2715', 'display_name': 'Gastroenterology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.80783623}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.6263755}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.43410963}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.35162976}], 'mesh': [{'descriptor_ui': 'D001327', 'descriptor_name': 'Autoimmune Diseases', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D009369', 'descriptor_name': 'Neoplasms', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D000911', 'descriptor_name': 'Antibodies, Monoclonal', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000074324', 'descriptor_name': 'Ipilimumab', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.7326/l18-0209', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S119722071', 'display_name': 'Annals of Internal Medicine', 'issn_l': '0003-4819', 'issn': ['0003-4819', '1539-3704'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316812', 'host_organization_name': 'American College of Physicians', 'host_organization_lineage': ['https://openalex.org/P4310316812'], 'host_organization_lineage_names': ['American College of Physicians'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/30014109', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.83}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 3, 'referenced_works': ['https://openalex.org/W2057823163', 'https://openalex.org/W2059712528', 'https://openalex.org/W2549481046'], 'related_works': ['https://openalex.org/W4389568370', 'https://openalex.org/W3108674512', 'https://openalex.org/W3032375762', 'https://openalex.org/W3031052312', 'https://openalex.org/W2748952813', 'https://openalex.org/W2586801360', 'https://openalex.org/W2080531066', 'https://openalex.org/W1995515455', 'https://openalex.org/W1506200166', 'https://openalex.org/W1489783725'], 'abstract_inverted_index': {'Letters17': [0], 'July': [1, 797, 813, 818], '2018Use': [2], 'of': [3, 10, 38, 59, 82, 106, 144, 156, 165, 180, 186, 200, 205, 220, 223, 229, 285, 291, 311, 333, 340, 363, 370, 393, 396, 400, 426, 488, 610, 621, 625, 645, 659, 677, 690, 700, 736, 759, 764, 768, 775, 786, 828], 'Immune': [4, 334, 364, 434, 454], 'Checkpoint': [5, 335, 365, 415, 419, 435, 455, 457, 489], 'Inhibitors': [6, 336, 366, 436, 458], 'in': [7, 147, 159, 258, 337, 367, 437, 444, 463, 491, 631, 663, 680, 706, 710, 761, 772], 'the': [8, 148, 154, 160, 178, 184, 218, 221, 224, 338, 368, 477, 688, 698, 737, 762], 'Treatment': [9, 339, 369], 'Patients': [11, 341, 371, 450, 492, 708, 711], 'With': [12, 342, 372, 493, 712], 'Cancer': [13, 42, 63, 86, 110, 315, 343, 373, 428, 438, 452, 681, 704], 'and': [14, 29, 100, 125, 227, 307, 344, 358, 374, 387, 421, 431, 441, 459, 465, 475, 486, 495, 604, 613, 647, 656, 709, 726, 729, 739, 750, 757, 780, 782], 'Preexisting': [15, 345, 375, 496], 'Autoimmune': [16, 346, 376, 497, 713], 'DiseaseNoha': [17], 'Abdel-Wahab,': [18, 35], 'MD,': [19, 23, 27, 33, 36, 80, 104, 506, 510, 515, 522, 527, 532, 543, 550, 555, 560, 564, 570, 576, 583, 587, 593, 597, 602, 607], 'PhD,': [20, 28, 511, 516, 523, 528, 533, 544, 551, 556, 561, 565, 571, 577, 584, 588, 598, 603], 'Mohsin': [21, 56, 351], 'Shah,': [22, 57], 'Maria': [24, 30, 77, 101, 354, 359], 'A.': [25, 78, 355], 'Lopez-Olivo,': [26, 79], 'E.': [31, 102, 360], 'Suarez-Almazor,': [32, 103], 'PhDNoha': [34], 'PhDUniversity': [37, 81, 105], 'Texas': [39, 45, 60, 66, 83, 89, 107, 113, 312, 318], 'MD': [40, 61, 84, 108, 313], 'Anderson': [41, 62, 85, 109, 314], 'Center,': [43, 64, 87, 111, 316], 'Houston,': [44, 65, 88, 112, 317], '(N.A.,': [46, 67, 90, 114, 319], 'M.S.,': [47, 68, 91, 115, 320], 'M.A.L.,': [48, 69, 92, 116, 321], 'M.E.S.)Search': [49, 70, 93, 117], 'for': [50, 71, 94, 118, 210, 481, 615, 619, 650, 687, 696, 732], 'more': [51, 72, 95, 119], 'papers': [52, 73, 96, 120], 'by': [53, 74, 97, 121, 153, 825], 'this': [54, 75, 98, 122], 'author,': [55, 76, 99], 'MDUniversity': [58], 'authorAuthor,': [123], 'Article,': [124, 306], 'Disclosure': [126, 308], 'Informationhttps://doi.org/10.7326/L18-0209': [127], 'SectionsAboutFull': [128], 'TextPDF': [129], 'ToolsAdd': [130], 'to': [131, 413, 718], 'favoritesDownload': [132], 'CitationsTrack': [133], 'CitationsPermissions': [134], 'ShareFacebookTwitterLinkedInRedditEmail': [135], 'IN': [136], 'RESPONSE:Because': [137], 'our': [138, 215], 'article': [139], 'was': [140, 168], 'a': [141, 288, 411, 632, 672], 'systematic': [142], 'review': [143, 735], 'reported': [145], 'cases': [146], 'literature,': [149], 'we': [150, 172], 'were': [151], 'limited': [152], 'quality': [155], 'information': [157, 176], 'available': [158], 'original': [161, 225], 'articles.': [162], 'Insufficient': [163], 'reporting': [164], 'certain': [166], 'data': [167], 'acknowledged.': [169], 'As': [170], 'such,': [171], 'did': [173], 'not': [174], 'report': [175], 'on': [177, 217], 'extent': [179], 'tumor': [181], 'mass': [182], 'at': [183, 327], 'time': [185], 'adverse': [187, 398, 692, 702, 716, 784], 'events.': [188], 'We': [189, 213], 'have': [190], 'included': [191], 'only': [192], 'reports': [193, 219], 'describing': [194], 'patients': [195, 292, 664], 'with': [196, 293, 451, 628, 634, 639, 665, 668, 746], 'an': [197, 790], 'established': [198], 'diagnosis': [199], 'autoimmune': [201, 231, 751], 'disease': [202], 'before': [203], 'initiation': [204], 'checkpoint': [206, 670, 719, 721, 788], 'inhibitor': [207, 479], '(CPI)': [208, 749], 'therapy': [209, 480], 'concomitant': [211], 'cancer.': [212], 'based': [214], 'determination': [216], 'authors': [222], 'articles,': [226], 'most': [228], 'these': [230], 'diseases—such': [232], 'as': [233, 410], 'psoriasis,': [234], '...References1.': [235], 'Fam': [236], 'AG.': [237], 'Paraneoplastic': [238, 256], 'rheumatic': [239, 397], 'syndromes.': [240], 'Baillieres': [241], 'Best': [242], 'Pract': [243], 'Res': [244], 'Clin': [245, 297], 'Rheumatol.': [246, 262], '2000;14:515-33.': [247], '[PMID:': [248, 264, 300], '10985984]': [249], 'CrossrefMedlineGoogle': [250, 267, 303], 'Scholar2.': [251], 'Manger': [252], 'B,': [253], 'Schett': [254], 'G.': [255], 'syndromes': [257], 'rheumatology.': [259], 'Nat': [260], 'Rev': [261], '2014;10:662-70.': [263], '25136782]': [265], 'doi:10.1038/nrrheum.2014.138': [266], 'Scholar3.': [268], 'Weber': [269], 'JS,': [270], 'Hodi': [271], 'FS,': [272], 'Wolchok': [273], 'JD,': [274], 'Topalian': [275], 'SL,': [276], 'Schadendorf': [277], 'D,': [278], 'Larkin': [279], 'J,': [280], 'et': [281], 'al.': [282], 'Safety': [283], 'profile': [284], 'nivolumab': [286, 629], 'monotherapy:': [287], 'pooled': [289], 'analysis': [290], 'advanced': [294], 'melanoma.': [295], 'J': [296], 'Oncol.': [298], '2017;35:785-92.': [299], '28068177]': [301], 'doi:10.1200/JCO.2015.66.1389': [302], 'Scholar': [304], 'Author,': [305], 'InformationAffiliations:': [309], 'University': [310], 'M.E.S.)Disclosures:': [322], 'Disclosures': [323], 'can': [324], 'be': [325], 'viewed': [326], 'www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M17-2073.': [328], 'PreviousarticleNextarticle': [329], 'Advertisement': [330], 'FiguresReferencesRelatedDetailsSee': [331], 'AlsoUse': [332], 'Disease': [347, 377, 498], 'Noha': [348], 'Abdel-Wahab': [349], ',': [350, 353, 357, 380, 383, 386], 'Shah': [352], 'Lopez-Olivo': [356], 'Suarez-Almazor': [361], 'Use': [362], 'Yasuo': [378], 'Oshima': [379], 'Noboru': [381], 'Hagino': [382], 'Masumi': [384], 'Hara': [385], 'Takashi': [388], 'Ohfuji': [389], 'Metrics': [390], 'Cited': [391], 'byManagement': [392], 'Cancer-Associated': [394], 'MyositisTreatment': [395], 'events': [399, 717], 'cancer': [401, 638, 646, 733], 'immunotherapyRespiratory': [402], 'ComplicationsBone': [403], 'Marrow–Liver–Thymus': [404], '(': [405], 'BLT': [406], ')': [407], 'Humanized': [408], 'Mice': [409], 'Tool': [412], 'Assess': [414], 'Inhibitor': [416], 'Adverse': [417, 447, 770], 'EventsImmune': [418], 'Blockade': [420], 'Skin': [422, 472], 'Toxicity': [423], 'PathogenesisPulmonary': [424], 'Complications': [425, 609], 'Lung': [427], 'TherapiesRheumatic': [429], 'Manifestations': [430], 'Diseases': [432], 'From': [433], 'ImmunotherapyReal-World': [439], 'Clinical': [440], 'Economic': [442], 'Outcomes': [443], 'Selected': [445], 'Immune-Related': [446], 'Events': [448, 771], 'Among': [449], 'Receiving': [453], 'InhibitorsImmune': [456], 'Kidney': [460], 'Toxicity:': [461], 'Advances': [462], 'Diagnosis': [464], 'ManagementPyroptosis-Related': [466], 'Gene': [467], 'Signatures': [468], 'Can': [469], 'Robustly': [470], 'Diagnose': [471], 'Cutaneous': [473], 'Melanoma': [474, 494], 'Predict': [476], 'PrognosisCheckpoint': [478], 'metastatic': [482], 'triple-negative': [483], 'breast': [484], 'cancerSafety': [485], 'Efficacy': [487], 'Inhibition': [490], 'A': [499], 'Cohort': [500], 'StudyMonique': [501], 'K.': [502], 'van': [503, 519, 535, 540, 568, 580, 591], 'der': [504, 581], 'Kooij,': [505], 'Karijn': [507], 'P.M.': [508], 'Suijkerbuijk,': [509], 'Maureen': [512], 'J.B.': [513], 'Aarts,': [514], 'Franchette': [517], 'W.P.J.': [518], 'den': [520, 541], 'Berkmortel,': [521], 'Christian': [524], 'U.': [525], 'Blank,': [526], 'Marye': [529], 'J.': [530, 573], 'Boers-Sonderen,': [531], 'Jesper': [534], 'Breeschoten,': [536], 'MSc,': [537], 'Alfonsus': [538], 'J.M.': [539], 'Eertwegh,': [542], 'Jan': [545], 'Willem': [546], 'B.': [547], 'de': [548], 'Groot,': [549], 'John': [552], 'B.A.G.': [553], 'Haanen,': [554], 'Geke': [557], 'A.P.': [558], 'Hospers,': [559], 'Djura': [562], 'Piersma,': [563], 'Rozemarijn': [566], 'S.': [567], 'Rijn,': [569], 'Albert': [572], 'ten': [574], 'Tije,': [575], 'Astrid': [578], 'A.M.': [579], 'Veldt,': [582], 'Gerard': [585], 'Vreugdenhil,': [586], 'Michiel': [589], 'C.T.': [590], 'Zeijl,': [592], 'Michel': [594], 'W.J.M': [595], 'Wouters,': [596], 'Olaf': [599], 'M.': [600], 'Dekkers,': [601], 'Ellen': [605], 'Kapiteijn,': [606], 'PhDNeurological': [608], 'Targeted': [611], 'Therapies': [612], 'Immunotherapies': [614], 'CancerInternational': [616], 'Consensus': [617], 'Guidance': [618], 'Management': [620], 'Myasthenia': [622], 'GravisMarked': [623], 'improvement': [624], 'oral': [626, 641], 'intake': [627], 'monotherapy': [630], 'patient': [633], 'microsatellite': [635], 'instability‐high': [636], 'gastric': [637], 'insufficient': [640], 'intakeSarcoidosisCheckpoint': [642], 'inhibitors:': [643, 671, 777, 789], 'Interface': [644], 'autoimmunity:': [648], 'Opportunity': [649], 'second': [651], 'level': [652], 'precision': [653], 'medicineIncidence,': [654], 'predictors,': [655], 'survival': [657], 'impact': [658], 'acute': [660], 'kidney': [661], 'injury': [662], 'melanoma': [666], 'treated': [667], 'immune': [669, 787], '10-year': [673], 'single-institution': [674], 'analysisMultinational': [675], 'Association': [676], 'Supportive': [678], 'Care': [679], '(MASCC)': [682], '2020': [683], 'clinical': [684], 'practice': [685], 'recommendations': [686], 'management': [689, 699, 779], 'immune-related': [691, 701, 715], 'events:': [693], 'pulmonary': [694], 'toxicityStrategies': [695], 'improving': [697], 'eventsLung': [703], 'Immunotherapy': [705], 'Transplant': [707], 'DiseasesCutaneous': [714], 'inhibitorsImmune': [720], 'inhibitor-induced': [722], 'inflammatory': [723, 753], 'arthritis:': [724], 'identification': [725], 'managementAutoimmune': [727], 'diseases': [728, 754], 'immune-checkpoint': [730, 776], 'inhibitors': [731, 748], 'therapy:': [734], 'literature': [738], 'personalized': [740], 'risk-based': [741], 'prevention': [742], 'strategyScleroderma-like': [743], 'syndrome': [744], 'associated': [745], 'pembrolizumabCheckpoint': [747], 'chronic': [752], '(ACIDs):': [755], 'tolerance': [756, 760], 'loss': [758], 'occurrence': [763], 'immuno-rheumatologic': [765], 'manifestationsA': [766], 'Review': [767], 'Immune-Mediated': [769], 'MelanomaAdverse': [773], 'effects': [774, 785], 'epidemiology,': [778], 'surveillanceEndocrine': [781], 'metabolic': [783], 'overview': [791], '(what': [792], 'endocrinologists': [793], 'should': [794], 'know)': [795], '17': [796, 812, 817], '2018Volume': [798], '169,': [799], 'Issue': [800, 815], '2Page:': [801], '133-134KeywordsAdverse': [802], 'eventsAutoimmune': [803], 'diseasesCancer': [804], 'treatmentCorticosteroid': [805], 'therapyDisclosureResearch': [806], 'designSystematic': [807], 'reviewsThyroid': [808], 'diseasesToxicityUlcerative': [809], 'colitis': [810], 'ePublished:': [811], '2018': [814, 819, 824], 'Published:': [816], 'Copyright': [820], '&': [821], 'PermissionsCopyright': [822], '©': [823], 'American': [826], 'College': [827], 'Physicians.': [829], 'All': [830], 'Rights': [831], 'Reserved.PDF': [832], 'downloadLoading': [833], '...': [834]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2883350403', 'counts_by_year': [{'year': 2024, 'cited_by_count': 7}, {'year': 2023, 'cited_by_count': 7}, {'year': 2022, 'cited_by_count': 6}, {'year': 2021, 'cited_by_count': 16}, {'year': 2020, 'cited_by_count': 14}, {'year': 2019, 'cited_by_count': 5}, {'year': 2018, 'cited_by_count': 2}], 'updated_date': '2025-01-04T19:10:59.952202', 'created_date': '2018-08-03'}